LINES
发表于 2025-3-28 15:28:38
Dennis Behrens,Carola Gerwig,Thorsten Schoormann,Ralf Knackstedtbinding sequence for the 3BP2 SH2 domain is present on diverse receptors and costimulatory molecules. Finally, the involvement of 3BP2 in the rare genetic bone disease cherubism raises the exciting possibility that 3BP2 acts as a “tumor suppressor” downstream from PTKs-coupled receptors in hematopoi
中止
发表于 2025-3-28 19:23:35
http://reply.papertrans.cn/87/8690/868967/868967_42.png
植物学
发表于 2025-3-28 23:58:38
http://reply.papertrans.cn/87/8690/868967/868967_43.png
heterodox
发表于 2025-3-29 04:29:07
http://reply.papertrans.cn/87/8690/868967/868967_44.png
阴险
发表于 2025-3-29 08:07:28
Paul Christoph Gembarski,Roland Lachmayerbinding sequence for the 3BP2 SH2 domain is present on diverse receptors and costimulatory molecules. Finally, the involvement of 3BP2 in the rare genetic bone disease cherubism raises the exciting possibility that 3BP2 acts as a “tumor suppressor” downstream from PTKs-coupled receptors in hematopoi
certain
发表于 2025-3-29 15:02:11
Stefan Wellsandt,Jürgen Anke,Klaus-Dieter Thobenbinding sequence for the 3BP2 SH2 domain is present on diverse receptors and costimulatory molecules. Finally, the involvement of 3BP2 in the rare genetic bone disease cherubism raises the exciting possibility that 3BP2 acts as a “tumor suppressor” downstream from PTKs-coupled receptors in hematopoi
SKIFF
发表于 2025-3-29 17:59:11
http://reply.papertrans.cn/87/8690/868967/868967_47.png
健谈
发表于 2025-3-29 22:43:21
http://reply.papertrans.cn/87/8690/868967/868967_48.png
Cryptic
发表于 2025-3-30 00:54:50
http://reply.papertrans.cn/87/8690/868967/868967_49.png
Merited
发表于 2025-3-30 04:04:25
http://reply.papertrans.cn/87/8690/868967/868967_50.png